SLC5A2 and type 2 diabetes mellitus: In the case of DKA development in a patient with presumed type 2 diabetes, consideration should be given to the accuracy of the diagnosis as Hamblin et al. showed that 22% of patients thought to have type 2 diabetes ended up being reclassified as having type 1 diabetes or LADA in both SGLT-2 users and non-SGLT-2 users [41].